Johnson & Johnson is downgraded to Hold, as valuation is now stretched after a 50% 12-month rally. JNJ trades above 21x forward EPS, exceeding its long-term average and offering a limited margin of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results